Education Library

Resources for Health Care Professionals

Filter Results

Condition

Audience

Topic

Type

Revascularization Completeness With pVAD vs IABP

In a third-party analysis conducted by the York Health Economics Consortium, IPD from contemporary studies were evaluated to test the hypothesis that PCI with Impella® support may be associated with a greater extent of revascularization.

Thursday Night Live: Putting the “I” Back in Team – Impella® Management in the ICU

Viktoriya Kagan, AGACNP-BC, CCRN, and Eddy Gutierrez, MD, discuss how to care for patients with cardiogenic shock and manage Impella® in the ICU.

A “Treasure Trove” of Complete Revascularization Data

Vasileios Panoulas, MD, discusses an individual patient data pooling from the PROTECT II RCT, PROTECT III and RESTORE EF trials released at EuroPCR 2023.

ECMO and pMCS for Advanced Cardiogenic Shock

Prof. Dr. Evgenij V. Potapov discusses combining extracorporeal life support (ECLS) with pMCS for treating advanced cardiogenic shock.

Subanalysis of Women in IMP-IT Registry

Alaide Chieffo, MD, discusses results from a subanalysis of women in the IMP-IT Registry in Italy.

Can I Bill for Daily Management of Impella®?

Are there billable services after Impella® insertion in the cath lab, such as ICU monitoring?

ECpella Therapy

Jacob Abraham, MD, Raymond Lee, MD, and Bindu Akkanti, MD, discuss ECpella therapy in this CAMP webinar moderated by Misty Casseus, MSN, RN.

Renal Recovery in HFCS with Impella 5.5® with SmartAssist®

Rohan Goswami, MD, discusses renal recovery in patients with heart failure cardiogenic shock (HFCS) supported with Impella 5.5® with SmartAssist®.

REVIVED-BCIS2 Interview: Gregg Stone and Divaka Perera

Gregg Stone, MD, FACC, FSCAI interviews Prof. Divaka Perera, professor of cardiology at Kings College in London, UK at the European Society of Cardiology (ESC) Congress 2022 in Barcelona, Spain.

TCT 2022: Limitations & Opportunities of Observational Database Analyses

Jay Giri, MD, discusses the pros, cons, and best uses for five types of observational database analyses.

TCT 2022: Cardiogenic Shock Working Group and SCAI Shock Stages

Navin Kapur, MD, provides an update from the Cardiogenic Shock Working Group and discusses the SCAI shock stages in this presentation from TCT 2022.

TCT 2022: Influential Trials in High-Risk PCI: Shaping the Future of Ischemic Heart Failure Therapy

Jonathan Hill, MD, discusses influential trials in high-risk PCI that are shaping the future of ischemic heart failure therapy.

TCT 2022: Data Integrity in Real-World Evidence

Robert Yeh, MD, discusses how we analyze data, make treatment decisions and participate in developing clinical evidence.

Case Study Epitomizing Results from RESTORE EF  

Aditya Bharadwaj, MD, an investigator for the RESTORE EF study, presents a case study epitomizing the results from the trial.

RESTORE EF Case Study: Contemporary Practices for Impella®-Supported Complete Revascularization

Jason Wollmuth, MD, describes best practice techniques for Impella-supported complete revascularization in a RESTORE EF case.

NPS-1674

This information is intended for use by customers, patients, and healthcare professionals in [region] only. We recognize that the Internet is a global communications medium; however, laws, regulatory requirements, and product information for medical products can vary from country to country. The product information included here may not be appropriate for use outside [region], and the information from other sites you visit may not be appropriate for use in [region].